Cam Gallagher

CIK 1557832 · President, Interim CFO · last filed 2026-04-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.39M

Companies

3

Total Filings

62

Lifetime Open-Market Net

-$21.93M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Opus Genetics, Inc. (OCUP) Delisted Director 2,098,797 $1.17 $2.46M $323.7K 14 2026-04-22
ZNTL President, Interim CFO 636,753 $3.75 $2.39M -$22.25M 45 2024-05-31
SRNE Director $0.00 $0 2 2014-01-24

Recent Filings · Page 3 of 7

62 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-10-17 ZNTL Sell (S) −12,500 -$293.9K EDGAR
2022-10-07 ZNTL Sell (S) −22,500 -$505.2K EDGAR
2022-09-16 ZNTL Sell (S) −22,500 -$560.3K EDGAR
2022-06-15 Opus Genetics, Inc. (OCUP) Delisted Grant (A) $0 EDGAR
2022-05-31 ZNTL Grant (A) +111,072 $0 EDGAR
2022-04-05 ZNTL Sell (S) −10,000 -$504.8K EDGAR
2022-03-16 ZNTL Sell (S) −10,000 -$419.2K EDGAR
2022-03-08 ZNTL Sell (S) −10,000 -$449.4K EDGAR
2022-02-15 ZNTL Sell (S) −10,000 -$519.3K EDGAR
2022-02-14 ZNTL Mixed +8,610 -$360.8K EDGAR
Showing 2130 of 62
Page 3 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.